Who owns Acer Therapeutics Inc?
- CUSIP Number: 00444p108
Tip: Access positions for across all investors
Analyze quarterly positions in Acer Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Acer Therapeutics stock
Who bought or sold Acer Therapeutics Inc this quarter?
There are no current stakeholders of Acer Therapeutics.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Acer Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Yakira Capital Management | Sep 2023 | 992k | $808k |
| Susquehanna International | Sep 2023 | 346k | $286k |
| Geode Capital Management | Sep 2023 | 137k | $113k |
| BlackRock | Sep 2023 | 77k | $64k |
| Union Square Park Capital Management | Sep 2023 | 27k | $22k |
| Northern Trust | Sep 2023 | 22k | $18k |
| Group One Trading | Sep 2023 | 3.2k | $2.6k |
| Tower Research Capital | Sep 2023 | 1.0k | $852.990900 |
| Ronald Blue Trust | Dec 2023 | 1.0k | $1.0k |